Xenco Medical

Xenco Medical, founded in 2011, has pioneered the development of the SETx Technology, a revolutionary concept at the convergence of materials science and biomechanical engineering. This innovative technology eliminates the cumbersome and costly processes associated with traditional implant systems. The spinal systems, based on highly reinforced, composite polymer, are packaged sterile and ready for use, with instruments disposed of after each surgery, ensuring a single-use implant system for every patient. The use of composite polymer in Xenco Medical’s patient-specific implant systems eliminates the risk of infection and cross-contamination that is associated with reused spinal implant systems. This represents a major breakthrough in ensuring patient safety and minimizing healthcare-associated risks. Moreover, the intuitive design of inserters pre-loaded with implants enhances efficiency in the operating room, addressing the growing need to optimize patient outcomes and streamline healthcare logistics. Xenco Medical's SETx Technology has gained traction across the United States due to its ability to eliminate costs associated with the autoclave process, delivery and retrievable processes, and surgery postponements due to sterilization errors. The company’s solution not only addresses crucial safety concerns but also offers operational efficiencies, which are increasingly essential in today’s healthcare landscape. As a part of the biotechnology and healthcare industries, Xenco Medical's innovative approach presents significant potential for transformative impact and promising growth prospects.